U.S. markets close in 2 hours 11 minutes
  • S&P 500

    4,247.60
    -7.55 (-0.18%)
     
  • Dow 30

    34,296.01
    -97.74 (-0.28%)
     
  • Nasdaq

    14,088.27
    -85.88 (-0.61%)
     
  • Russell 2000

    2,317.65
    -8.50 (-0.37%)
     
  • Crude Oil

    72.01
    +1.13 (+1.59%)
     
  • Gold

    1,856.80
    -9.10 (-0.49%)
     
  • Silver

    27.69
    -0.35 (-1.24%)
     
  • EUR/USD

    1.2130
    +0.0007 (+0.06%)
     
  • 10-Yr Bond

    1.5040
    +0.0030 (+0.20%)
     
  • GBP/USD

    1.4085
    -0.0023 (-0.16%)
     
  • USD/JPY

    110.0760
    +0.0150 (+0.01%)
     
  • BTC-USD

    40,423.87
    +207.30 (+0.52%)
     
  • CMC Crypto 200

    1,006.35
    -4.26 (-0.42%)
     
  • FTSE 100

    7,172.48
    +25.80 (+0.36%)
     
  • Nikkei 225

    29,441.30
    +279.50 (+0.96%)
     

BREAKING ALERT: Rosen Law Firm Encourages AVROBIO, Inc. Investors with Losses to Inquire About Class Action Investigation – AVRO

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of AVROBIO, Inc. (NASDAQ: AVRO) resulting from allegations that AVROBIO may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased AVROBIO securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to http://www.rosenlegal.com/cases-register-1814.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On May 3, 2021, before market hours, AVROBIO issued a press release entitled "AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease" which announced that "AVROBIO can no longer pursue an accelerated approval pathway for AVR-RD-01 with the FAB-GT trial as currently designed[.]"

On this news, AVROBIO share prices fell $2.20 per share, or 18%, to close at $9.48 on May 3, 2021.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005980/en/

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com